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Abstract in Bahasa Melayu 
Pengenalan: Semburan hidung corticosteroid adalah salah satu rawatan yang paling berkesan 
dalam penyakit resdung. Terdapat pelbagai jenis semburan hidung corticosteroid di Malaysia. 
Walaupun bahan utama dalam semburan hidung adalah produk berasaskan steroid, perbezaan 
kepekatan boleh memberikan kesan yang berbeza dalam mengawal gejala alahan resdung. 
Pertimbangan dalam kepekatan adalah penting bagi penyedian ubatan dan boleh 
mempengaruhi penyerapan, pengekalan dan seterusnya keberkesanan serta keselamatan ubat.  
Objektif: Kajian ini dijalankan untuk menentukan keberkesanan jenis semburan hidung 
dalam merawat resdung dengan membandingkan keberkesanan menggunakan beberapa 
parameter klinikal iaitu; TNSS, SNOT-22 dan pemeriksaan nasoendoskopik ‘Modified Lund-
Kennedy’. Keberkesanan juga ditentukan dengan menguji penanda radang alahan seperti 
serum Interleukin-4 dan kiraan eosinofil dalam darah.  
Kaedah: Kajian Perbandingan Intervensi, label terbuka yang melibatkan 2 kumpulan 
(kumpulan semburan hidung hipotonik dan kumpulan semburan hidung isotonik) telah 
dijalankan di klinik Otorinolaringologi Hospital Sultanah Nur Zahirah Kuala Terengganu dan 
Klinik Otorinolaringologi Hospital Universiti Sains Malaysia Kubang Kerian Kelantan 
bermula dari Jun 2015 hingga Mei 2016. Kajian melibatkan pesakit luar yang berumur dari 
18-70 tahun, yang dirawat di klinik dan disahkan menghidap resdung berdasarkan gejala dan 
telah bersetuju untuk ujian ‘skin prick test’.  
Keputusan: Statistik ANOVA digunakan untuk melihat keberkesanan di antara semburan 
hidung isotonik dan hipotonik yang meliputi ‘Total Nasal Symptom Score (TNSS)’, 
‘Sinonasal Outcome Test–22(SNOT-22)’ dan pemeriksaan nasoendoskopik ‘Modified Lund-
Kennedy’. Hanya pemeriksaan nasoendoskopik ‘Modified Lund-Kennedy’ menunjukkan 
perbezaan di antara kedua-dua kumpulan ini, F = -2.23, p = 0.026. Ujian Mann Whitney 
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digunakan dimana median (IQR) untuk semburan hidung hipotonik = 3.00 (4.00) dan 
semburan hidung isotonic = 2.00 (4.00). Bagi penilaian makmal, keberkesanan antara kedua-
dua kaedah semburan dianalisa menggunakan statistik t-test. Untuk ujian IL-4, perbezaan min 
antara semburan hidung isotonik dan hipotonik adalah tidak signifikan (p = 0.337, 95% CI-
0.91, 0.32). Keputusan ujian kiraan eosinofil juga menunjukkan tidak signifikan (p = 0.190, 
95%CI -0.38, 0.08).   
Rumusan: Tidak banyak perbezaan keberkesanan antara semburan hidung isotonik dan 
hipotonik menggunakan parameter klinikal dan penilaian makmal. Dalam kajian ini, hanya 
pemeriksaan nasoendoskopik ‘Modified Lund-Kennedy’ menunjukkan statistik signifikan 
menggunakan semburan hidung isotonik. Sebagai rumusan, semburan hidung isotonik 
menunjukkan hanya sedikit kelebihan dari semburan hidung hipotonik dalam mengawal 
gejala alahan resdung.   
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Abstract in English 
Background: Intranasal corticosteroid spray is one of the most effective treatment in allergic 
rhinitis. There are various types of intranasal corticosteroid spray available in Malaysia. 
Although the main ingredient in nasal spray is steroid-based products, the difference of 
tonicity could show different effect in controlling the symptoms of allergic rhinitis. Tonicity 
is an important consideration for drug formulation and can affect its uptake, retention and 
consequent efficacy and safety.  
 
Objective: This comparison study is to determine the efficacy of different type of nasal spray 
in treatment of allergic rhinitis by comparing the efficacy using several clinical parameters 
that are Total Nasal Symptom Score (TNSS), Sinonasal Outcome Test Score-22 (SNOT-22) 
and Modified Lund-Kennedy (MLK) nasoendoscopic examination. Efficacy is also 
determined with allergy inflammatory markers such as serum Interleukin-4 and blood 
eosinophilic count.  
 
Methods: Comparative interventional study, open label involving 2 groups (hypotonic nasal 
spray group and isotonic nasal spray group) was carried out in Otorhinolaryngology Clinic of 
Hospital Sultanah Nur Zahirah Kuala Terengganu and Otorhinolaryngology Clinic of 
Hospital Universiti Sains Malaysia Kubang Kerian Kelantan commencing from June 2015 till 
May 2016. Study involves walk-in patient aged from 18-70 years old, who are seen in clinic 
from this two centres that are diagnosed with allergic rhinitis based on symptom and sign and 
had consented for skin prick test.  
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Results: ANOVA test was applied to study the efficacy of isotonic and hypotonic nasal spray 
which includes TNSS, SNOT-22 and Modified Lund-Kennedy nasoendoscopic examination 
score. Only Modified Lund-Kennedy nasoendoscopic score showed significant difference 
between the two groups, F = -2.23, p = 0.026. Mann Whitney test was applied, median (IQR) 
for hypotonic spray =3.00(4.00) and isotonic spray 2.00(4.00). For inflammatory markers, 
effects of both method were analysed by using t-test. For IL-4, the difference between the 
mean isotonic and hypotonic nasal spray was not statistically significant (p = 0.337, 95% CI-
0.91, 0.32). Same findings were demonstrated in eosinophil counts which showed no 
statistically different (p = 0.190, 95%CI -0.38, 0.08).   
 
Conclusions: There is not much difference on the efficacy between isotonic and hypotonic 
using clinical parameters and allergic inflammatory markers. The only significant findings in 
this study is by using the Modified Lund-Kennedy nasoendoscopic score which shows 
improvement with isotonic nasal spray.  As a conclusion, isotonic INSs has a slightly superior 
efficacy than hypotonic INSs for treatment of AR in reducing the signs and symptoms.  
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CHAPTER 1: INTRODUCTION 
 
Allergic rhinitis (AR) is a common hypersensitivity reaction that affect our community and 
worldwide. It is a disease of inflammatory reaction in the nasal mucosa due to immunological 
response towards offending allergen. The inflammatory reactions occur due to 
hypersensitivity of nasal mucosa through immunoglobulin E (IgE) mediated antibodies which 
is also well known as hypersensitivity type 1 (Skoner, 2001).  The prevalence of AR is 
increasing and has become a major health problem in many countries. Although it is not 
associated with direct mortality, it carries a significant morbidity and has a huge 
socioeconomic burden. It may impacts quality of life of a patient such as poor productivity, 
lack of sleep and emotional disturbances. For school-age children with allergic rhinitis, they 
may miss school, had poor performance in classrooms and limit them in school activities.  
 
Worldwide, it is estimated around about 400 million people suffer from AR (Pawankar et al., 
2012). In Malaysia, prevalence of AR among Malaysian population was about 38%-40% (Ho 
et al., 2011) and AR among children is half that of the adult population which is about 27% 
(Quah et al., 2005).  As it is a relatively common problem encountered in the community, 
various studies have been done to understand the disease better.  
 
Management of AR is costly. In fact, a study done from 2001 to 2005 in England showed a 
41.7% overall increase in prescriptions for antihistamines and drugs used in nasal allergy 
(Ghouri et al., 2008). It may also impact productivity of an organization due to miss work 
among workers which affect the economic growth. In the United States, AR results in 3.5 
million lost workdays and 2 million lost schooldays annually. Patients often struggle to 
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alleviate their misery, by self-adjusting their treatment regimen using over-the-counter 
medications because of the lack of efficacy, deterioration of efficacy, lack of 24-hour relief, 
and bothersome side effects (Nathan, 2007). 
 
Clinically, AR is characterized by 4 cardinal symptoms which are sneezing, rhinorrhoea, 
itchy nose and nasal blockage. These symptoms are aggravated when patient are exposed to 
allergen such as house dust mite, seafood, pollen and others. The most common aero-
allergens like dust-mites, pollens and animal dander are responsible for many of the 
sensitivity reactions in allergic rhinitis. 
 
Study of AR patients in Kelantan showed almost 50% of AR patients are due to seafood 
allergies, followed by chicken-based food. Of particular interest, among local Kelantanese 
most commonly induced seafood allergy was the anchovy sauce (Asha'ari et al., 2010). 
 
The classification of AR can be intermittent or persistent and its severity can be either mild, 
moderate or severe as advocated by Allergic Rhinitis and its Impacts on Asthma (ARIA) 
Guidelines 2008 (Pawankar et al., 2012). The standard treatments of AR are avoidance of 
allergen, oral antihistamines and intranasal corticosteroid. Currently there are many available 
types of intranasal corticosteroid in the markets with mostly in isotonic solution. Since past 
few years, there is a new intranasal corticosteroid in the market which is hypotonic solution. 
It is believed to be more rapid and longer acting. There are many studies done comparing 
intranasal corticosteroid with placebo, but so far there is no study done to compare between 
isotonic and hypotonic intranasal corticosteroid spray. 
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Physiologically, tonicity is a property of a solution in reference to a particular membrane. In 
regards to cell tissue tonicity, it is the net osmolar gradient across the cell membrane. 
Tonicity is important for predicting the overall outcome of any changes in osmolality because 
it allows these solutes to cross the cell membrane in a tissue. Hence all tissue in human body 
is in osmotic equilibrium with each other. Movement of water across cell membranes occurs 
continuously until intracellular and extracellular tonicities are equal (Homer et al., 2000).  
 
According to basic physiology tonicity of molecule, a solution is defined as a homogeneous 
mixture of two or more substances. One of the substances is called a solvent (a substance in 
which other substance or substances are dissolved). The substances dissolved in a solvent are 
called solutes (Rohrscheib et al., 2015).  
 Isotonic solutions are two different solutions that have the same solute 
concentration.  
 Hypertonic solution is two different solutions in which one solution has a 
higher solute concentration.  
 Hypotonic solution is two different solutions in which one solute has a lower 
solute concentration.  
Tonicity plays an important role in treating or reducing the clinical symptoms and signs of a 
disease. Theoretically, isotonic molecules will stay at the same tonicity with the nasal mucosa 
and it has tendency to dwell longer. In contrast, it was postulated that hypotonic molecules 
will have rapid absorption into the nasal mucosa compared to isotonic solution (Sato et al., 
2007). This advantage can be utilized for pharmacology use in treating common problems in 
AR. 
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Various type of INSs with different preparation are currently available for the treatment AR. 
Different tonicity suspension may give different efficacy in alleviating symptoms of AR. 
Previous publication were mainly focus on comparison of existing INSs with placebo on the 
aspect of efficacy and safety. However, limited study were done to asses between different 
types of INSs in improvement of AR symptoms. Therefore this study can be a starting point 
to explore further in terms of clinical and laboratory data in patient with AR.  
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CHAPTER 2: LITERATURE REVIEW 
2.1 Anatomy and Physiology of the nose 
Better understanding of the anatomy and physiology of the nose will help in the treatment of 
patient with AR. External nose is pyramidal in shape with its root up and the base is directed 
downward. This nasal pyramid is made of osteocartilagenous and membranous framework 
covered by skin (Figure 1). The upper one third of the external nose is bony while the lower 
one third is cartilaginous. The bony part consists of two nasal bones that meet in the midline 
and rest on the upper part of nasal process of the frontal bone. Laterally, these bones are held 
between the frontal processes of the maxilla. Whereas the cartilaginous part is consists of 
upper and lower lateral cartilage, lesser alar or sesamoid cartilages and septal cartilage that 
formed the nasal septum (Netter,2014) 
 
Figure 2.1 - Osteocartilagenous framework of nose 
(Figure adapted from Neil S. Norton, Netter’s Head and Neck Anatomy for Dentistry: 
Saunders Elsevier Inc 2007, 152) 
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Internal nose is divided into right and left cavities by the nasal septum. Each nasal cavity 
communicates with the exterior through nostril and with the nasopharynx through the 
posterior nasal aperture or the posterior choana. Each nasal cavity consists of skin-lined 
portion, the vestibule and a mucosa line portion, the nasal cavity proper. Vestibule is lined by 
skin and contains sebaceous glands, hair follicles and hair also known as vibrissae. Its upper 
limit on the lateral wall is marked by limen nasi which is formed by the caudal margin of 
upper lateral cartilage. Its medial wall is formed by the columella and lower part of the nasal 
septum up to its mucocutaneous junction(Netter, 2014). 
 
Each nasal cavity is bounded with the lateral and medial wall, the roof and the floor. Medial 
wall is made up from the nasal septum. Lateral wall is formed by three scrolls like projections 
namely inferior, middle and superior turbinates (Figure 1). Below and lateral to each 
turbinate is the corresponding meatus. Each of the meatus has their own openings from the 
paranasal sinuses. In the inferior meatus, there is nasolacrimal ducts opening that drain the 
tears from the eyes into the nose and eventually get swallowed through the nasopharynx. 
Maxillary, frontal and anterior ethmoidal and sphenoid sinuses open into the middle meatus. 
The openings allow the drainage of mucus from correspond paranasal sinuses into the nasal 
cavity then into the nasopharynx. This process is regulated by the delicate and a well 
organized mucociliary clearance of nasal epithelium mucosa. 
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Figure 2. 1 - Lateral Wall of Nasal Cavity 
(Figure adapted from Kirschner, Celeste G. Netter's Atlas of Human Anatomy Elsevier Inc 
2005, Chapter: Head and Neck Page: 30) 
The nasal cavity is generally lined by the pseudostratified ciliated columnar epithelium which 
contains goblet cells except at the roof. Approximately one to two centimetres from the 
cribriform plate and its corresponding lateral wall is lined by olfactory epithelium that 
contains olfactory receptors which is responsible for smell. The respiratory epithelium that 
lines the majority of the nasal cavity are responsible for humidification and warming the air, 
filtering the air from foreign particles and killing microbes via the mucus that they produced 
which contain plenty of enzymes and antibodies in it (Costanzo, 2014). 
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The nose is the primary organ of smell and part of the respiratory system. Apart from that, the 
nose is the one of important organ that functions in sensing smell. There are other several 
interesting functions of the nose (Table 2.1) 
 
Table 2.1: Physiological Functions of the Nose (adapted from Scott-Brown's 
Otorhinolaryngology, Head and Neck Surgery 7th edition) 
 
Function  Mechanism 
a) Respiration 
 Heat exchange 
 
 Humidification 
 Filtration 
 Nasal resistance 
 Nasal fluid and ciliary functions 
 Nasal neurovascular reflexes 
 
b) Voice modification 
c) Olfaction 
 
 
 Direction of blood flow, evaporation 
heat 
 Capillary permeability 
 Laminar/turbulent flow 
 Anatomical and neurovascular 
 Mucus, mucins 
 Sympathetic or parasympathetic 
 
Nasal escapes 
Perceived smell through pathways to higher 
centres 
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2.3 Definition of Rhinitis 
 
Rhinitis is defined as an inflammatory condition of the nasal mucosa characterized by four 
cardinal symptoms which are sneezing, rhinorhea, itchiness and nasal blockage. There are 
many classification of rhinitis such as perennial or seasonal, allergic or non-allergic and 
intrinsic or extrinsic allergic rhinitis (Small and Kim, 2011). 
 
Previous studies classified AR as seasonal or perennial, according to the occurrence of 
symptoms during the year and the type of allergen. Typically, seasonal AR is caused by a 
variety of outdoor allergens, mainly pollen, whereas perennial AR is mostly related to indoor 
allergens, such as house dust mite, pets, and cockroaches. The distinction between seasonal 
and perennial AR, however, is not applicable to all patients (e.g., concomitant sensitization to 
indoor- and outdoor allergens) and in all countries (e.g. perennial occurrence of pollen). The 
general classification of AR, therefore, has been revised by the ARIA (Allergic Rhinitis and 
its Impact on Asthma) workshop group, a World Health Organization initiative. Based on 
duration of symptoms, ARIA classifies AR as ‘intermittent’ or ‘persistent’ and depending on 
the impact of the disease on quality of life or daily activities into ‘mild’ or ‘moderate/severe’. 
It was recently suggested to label the latter category just ‘severe’ as the vast majority of 
patients in this ARIA category reported symptoms affecting two or more quality of life 
criteria such as daily activities, work, or sleep (Keil et al., 2010) 
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2.4 Epidemiology  
 
AR is one of the most widespread chronic inflammatory diseases. Worldwide, the prevalence 
of allergic diseases such as AR and asthma are markedly increased to epidemic proportions. 
An estimated 300 million persons worldwide have asthma and about 400 million people 
suffer from AR. AR affects 10% to 20% of the general population in Europe and the United 
States of America (Ozdoganoglu and Songu, 2012). AR has a marked impact on quality of 
life, school absenteeism among school children, sick leave among workers and thus it causes 
huge socioeconomic burden to many countries (Pawankar et al., 2012). Furthermore, AR 
accounts up to 40% of children aged group,  and it is associated with numerous complications 
and also been considered a risk factor for asthma (Berger, 2004).  
 
The International Study of Asthma and Allergies in Childhood (ISAAC) Phases Three 
observed a rise in prevalence of asthma, allergic rhinoconjunctivitis and eczema after five 
years duration from ISAAC Phase One Study across Asia Pacific region (Asher et al., 2006). 
In the adolescent group, the Asia Pacific region was in the mid-range for reported symptoms 
of rhinoconjunctivitis at a global scale. However, the prevalence in Hong Kong and Bangkok 
were among the highest recorded worldwide. In the 6 to 7-year-old group, Asia Pacific had a 
fairly high prevalence of  rhinoconjunctivitis ranked as the third highest region globally 
(Wong et al., 2013) 
 
In South East Asia, the prevalence of allergic rhinitis differs between countries and even 
between areas within countries (Asher et al., 2006). These differences may partly be due to 
different definitions and methods used. Study done  in Vietnam shows 50.2% of their 
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population are suffering from AR. Prevalence between urban and rural area showed 
considerably higher rates in urban compared to rural about 29.6% to 10.0% respectively 
(Lâm et al., 2011). In addition, allergic disorders are common in Singapore and prevalence is 
comparable to some populations in the West. The prevalence of AR was 44% in which are 
more common in higher socioeconomic status group (Goh et al., 1996). 
House dust mites are the most common indoor allergens for allergic diseases such as AR and 
asthma. In tropical country with warm and humid climate, it has high prevalence of house 
dust mite. It is commonly found in association with bedding products, carpets, curtains and 
fabric products. Nowadays, lifestyle changes showed people spend more times often indoor 
that will increased exposure to indoor allergens. In Malaysia, there is increasing prevalence 
of AR and asthma with increased sensitivity towards house dust mite which is contributed by 
the improvement in socioeconomic status, westernized life styles and home environments 
conducive to proliferation of house dust mite(Sinniah and Thakachy, 2014).  
 
Nevertheless AR affects both adult and a children group in many countries and it remains 
largely undiagnosed in certain region worldwide due to low socioeconomic condition as poor 
hygiene that lead to expose to an allergens as well as difficulty in medical access and lack of 
study research done. 
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2.5 Pathophysiology 
 
The immune system of human’s body has innate and adaptive response (Figure 2). The 
functions of the adaptive immune response are the recognition of specific “non-self” antigens 
or “self” antigens. The adaptive immune response regulates the generation of pathogen-
specific immunologic effector pathways that eliminates specific pathogens or pathogen-
infected cells. The cells of the adaptive immune system are T cells, which are activated 
through the action of antigen presenting cells (APC) and B cells (Liu et al., 2012). 
 
Our immune system is continuously exposed to a wide variety of disturbances. Such 
disturbances are recognized by T cells via antigen presentation. Antigen presentation is a 
process in which antigen presenting cells (APC) capture the antigens, break them into small 
peptides, couple them with MHC molecules, and present them on the cell surface, thus 
enabling their recognition by T cells (Khailaie et al., 2013). 
 
AR is a condition of an inflammation of the mucous membranes of the nose, paranasal 
sinuses, eyes, eustachian tubes, middle ear and pharynx. In certain people, other organs may 
also be affected. The inflammation of the mucous membranes is characterized by a complex 
immunological cascade releasing inflammatory mediators. This is triggered by 
immunoglobulin E (IgE) - mediated response to an extrinsic protein or polysaccharides which 
is called allergen. This inflammatory condition is described as hypersensitivity type 1 
reaction (Warrington et al., 2011) 
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Hypersensitivity type 1 is characterized by local and systemic manifestation of Ig-E mediated 
hypersensitivity. It is a process of IgE-mediated inflammatory disease of the nasal mucous 
membranes due to the interaction of allergen characterized by an inflammatory infiltrate 
made up of eosinophils, T cells, mast cells and basophils, which release several mediators, 
chemokines and cytokines (among these, histamine and cysteinyl-leukotrienes are the major 
vasoactive mediators), regulation of the local and systemic IgE synthesis, and communication 
with the immune system and the bone marrow (Naclerio, 1991). AR patient can be allergic to 
inhalants (aeroallergen) and food allergen. However, aeroallergen can induce activation of 
mechanism of AR of early and late phase allergic reactions. After deposition and elution of 
allergens into the mucus layer, the allergens are taken up by antigen presenting cells and 
processed and presented to helper T lymphocytes. Activated helper T lymphocytes release 
cytokines like IL-4 and IL-13 and interact with B lymphocytes to induce the synthesis of 
allergen specific IgE. Thereafter, the allergen-specific IgE binds to the high affinity receptor 
for IgE on the surface of mast cells (Pawankar et al., 2011). 
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Figure 2.2 - Adaptive Immunity 
(Adapted from figure of Neoreviews Vol. 6 No. 10 October 01, 2005, published online 
September 30, 2005 pp. e454-e462.doi: 10.1542/neo.6-10-e454) 
 
Basically, pathophysiology of AR can be divided into 4 stages namely sensitization, early 
phase, late phase and systemic activation (Michael Gleeson, 2008). (Figure 2.2) 
 
Sensitization 
Once allergen such as grass pollen, house dust mite, cat dander are inhaled and deposited into 
the mucus layer which cannot be clear up by mucociliary clearance, the allergens are 
engulfed by antigen presenting cells (APC) such as dendritic cells called Langerhans cells. 
They are then processed and then presented to helper T lymphocytes. Activated helper T 
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lymphocytes release cytokines like IL-4, IL-5 and IL-13 and interact with B lymphocytes to 
induce the synthesis of allergen specific IgE. Thereafter, the allergen-specific IgE binds to the 
high affinity receptor for IgE on the surface of mast cells. A mast cell is a type of granulocyte 
derived from myeloid stem cell that plays a role in mediating allergic response and contains 
granules and chemical mediators such as histamine, cytokines, granulocyte macrophage 
colony-stimulating factor, leukotrienes, heparin and many proteases causing symptoms of 
allergy (Pawankar et al., 2011). 
 
Early phase response 
The early or immediate phase response occurs in sensitized individuals within minute of 
exposure to the same allergen and it lasts for about 2-3 hours. One of the cardinal 
components of the early phase response is the degranulation of mast cells. In the sensitized 
individual, mast cells are abundant in the epithelial compartment of the nasal mucosa and can 
be easily activated upon re-exposure to the allergens. Upon crosslinking of the allergen 
specific IgE bound to the surface of mast cells by the specific allergen, mast cells degranulate 
and release a variety of pre-formed and newly formed mediators leading to what is known as 
the early phase response (Klimek and Schendzielorz, 2008).  
 
Histamine which is secreted by basophils and mast cells is the major mediator of AR, 
stimulates the sensory nerve endings of the trigeminal nerve and induces sneezing. Histamine 
also stimulates the mucous glands to secrete mucous causing rhinorrhoea. At the same time, 
histamine, leukotrienes and prostaglandins act together on the blood vessels causing 
congestion of nose (van Cauwenberge et al., 2000). 
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Late phase response 
The late phase response occurs 4-6 hours after antigen stimulation. This phase is 
characterized by prolongation of symptoms of sneezing, rhinorrhoea but most predominantly 
a sustained nasal congestion which lasts for about 18-24 hours (Min, 2010). The late phase 
response is predominantly inflammatory in nature and is characterized by inflammatory 
cellular influx comprising of predominantly T lymphocytes, basophils and eosinophils. A 
variety of mediators are released by these cells including leukotrienes, kinins, histamine 
which results in the continuation of the symptoms and the development of the late phase.  
 
The key to the orchestration of the late phase response lies in the production and release of a 
variety of cytokines and chemokines like IL-4, IL-13 from mast cells (Prussin and Metcalfe, 
2006). These cytokines can upregulate the expression of 'adhesion molecules' like vascular 
cell adhesion molecule 1 (VCAM-1) on the endothelial cells facilitating the infiltration of 
eosinophils, T lymphocytes and basophils into the nasal mucosa. In addition, chemokines like 
RANTES, eotaxin, MCP-4 and Thymus and Activation - Regulated Chemokine (TARC) 
released from epithelial cells serve as chemoattractants for eosinophils, basophils and T 
lymphocytes (Kay, 2001). Other action of other cytokines such as granulocyte-macrophage 
colony stimulating factor (GM-CSF) released largely by epithelial cells and IL-5 from mast 
cells prolong the survival of the infiltrated eosinophils in the nasal mucosa leading to 
persistent symptoms of allergy (Togias, 2000). In addition, a variety of other mediators 
released like eosinophil cationic protein (ECP), platelet activating factor, major basic protein 
(MBP) are also implicated in the late phase response. 
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Figure 2. 3- Pathophysiology of Allergic Rhinitis 
(Adapted from Drugs Today 2003, 39(6): 451, ISSN 1699-3993, CCC: 1699-3993 DOI: 
10.1358/dot.2003.39.6.799450)   
 
 
 
 
 
 
 18 
 
2.6 Diagnosis 
 
The diagnosis of IgE-mediated hypersensitivity diseases is routinely based on 4 parameters of 
evidence. Three types are part of the clinical work-up for allergy which involves a detailed 
patient history and physical examination, skin testing and in certain condition, challenge 
testing with suspected allergen. The fourth type involves laboratory procedure which 
commonly utilizes in vitro determination of circulating serum IgE antibodies specific for 
allergen (Kranke and Aberer, 2009). 
 
Thorough history taking can be aided using standard questionnaire such as Total Nasal 
Symptoms Score (TNSS) which can assess the severity of the disease impacts to the patient’s 
quality of life. All relevant past history, other medical co-morbidites, dietary, drugs and 
allergy history as well as social history such as environmental and occupational exposure 
needs to be elucidated. Undoubtedly, not to be forgotten to ask the main complaint of the 
patient which lead to the four cardinal symptoms of allergic rhinitis namely sneezing, 
rhinorhea, itchiness and nasal blockage.  
 
There are many differential diagnosis of allergic rhinitis and one of them includes non-
allergic rhinitis (NAR) which subdivided into 8 major subtypes which includes nonallergic 
rhinopathy (previously known as vasomotor rhinitis), nonallergic rhinitis with eosinophilia, 
atrophic rhinitis, senile rhinitis, gustatory rhinitis, drug-induced rhinitis, hormonal-induced 
rhinitis, and cerebral spinal fluid leak (Tran et al., 2011). 
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Physical examination should be included to assess general condition of the patient and to look 
for obvious allergic signs such as allergic shiners which is a dark circles around the eyes and 
allergic nasal crease or allergic salute which is a horizontal crease across the lower half of the 
nasal bridge due to repeated upward rubbing of the tip of the nose. A full ear, nose, throat 
examination is performed emphasizing on the other sign of allergy in ocular, pharynx and 
larynx. Current approach advocated that nasal endoscopy offers an advantage of global 
evaluation of the endonasal cavity compare to the anterior or posterior rhinoscopy 
examination (Scadding et al., 2011). Besides that, the scoring methods also valuable in 
management of allergic rhinitis during follow up (Table 2.2). 
 
Table 2. 2- Endoscopic Appearance Score 
Adapted from; Laryngoscope. 2014 Oct; 124(10):2216-23. doi: 10.1002/lary.24654. Epub 
2014 Apr 2 Modification of the Lund-Kennedy system by excluding the subscores of scarring 
and crusting improves its reliability (Psaltis et al., 2014). 
Characteristic Right nasal cavity Left nasal cavity 
Polys (0,1,2)   
Edema (0,1,2)   
Secretions (0,1,2)   
Total   
 
Scoring: 
 0 1 2 
Polyp  Absent  Limited to middle 
meatus 
Extend into the nasal 
cavity 
Mucosal oedema Absent  Mild/moderate 
oedema 
Polypoid 
degeneration 
Secretion  Absent  Hyaline  Thick and/or 
mucopurulent 
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2.6.1 Symptoms and Signs 
AR showed immediate-type allergic symptoms of sneezing, rhinorhea, itchiness and nasal 
obstruction. Manifestation of AR symptoms varies depending on its severity to a patient 
based on impairing daily activities such as repetitive sneezing, severe rhinorhea causing nasal 
congestion, loss of smell and postnasal drip, itchy red eyes and excessive tearing, fatigue and 
malaise.  Current approach for the management of AR follows the Allergic Rhinitis and its 
Impact on Asthma (ARIA) Guidelines (Pawankar et al., 2012). 
 
The ARIA classification introduced a systematic approach for assessing severity of AR on 
the basis of the presence or absence of impairment in any of 4 health-related quality of 
life(HRQL) items which are sleep, daily activities/sport, work/school and troublesome 
symptoms. ARIA workshop group defines AR as mild when there was no impairment in any 
of these items and moderate or severe when there was impairment in one or more areas.   
Table 2. 3- Classification of Allergic Rhinitis based on duration 
 
Intermittent symptoms Persistent symptoms 
Less than 4 days per week or 
Less than 4 weeks per year 
More than 4 days per week  
More than 4 weeks per year 
 
Table 2. 4-Summary of ARIA classification (combination of duration and severity) 
Mild Moderate  to Severe (one or more items) 
Normal sleep 
Normal daily activities, sport, leisure 
Normal work and school 
No troublesome symptom 
Abnormal sleep 
Impairment of daily activities, sport, leisure 
Problem caused at work and school 
Troublesome symptom 
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In certain centres, patient with symptoms of AR, need to undergo nasoendocope examination 
for evaluation of the whole nasal cavity, septum, nasopharynx and also the area of middle 
meatus which has clinical importance in rhinosinusitis. However, some centre only 
performed anterior rhinoscopy for diagnosing AR without any other laboratory testing. 
According to the Joint Task Force on Practice Parameters by the American Academy of 
Allergy, Asthma & Immunology (AAAAI) and the American College of Allergy, Asthma 
and Immunology (ACAAI) advocates that the nasal and oropharyngeal examination may be 
accomplished with a nasal speculum with appropriate lighting, otoscope with nasal adapter, 
indirect mirror, and/or rigid or flexible nasopharyngoscope, based on the expertise of the 
examiner and/or the assessment needs (Wallace et al., 2008). 
 
2.6.2 Skin Prick Test 
 
A skin test for allergic testing is widely used among physicians. There are 2 types of skin test 
which are epidermal and percutaneous test. Examples of epidermal test are patch test and 
friction test whereas percutaneous test for example are skin prick test (SPT), scratch test and 
transdermal test. 
 
Rapid detection of allergen specific IgE is an essential tool in the clinical practice of allergy. 
Remarkably, the skin prick test is the most widely used diagnostic test in allergy because it is 
simple, quick and most sensitive method detecting specific IgE. Therefore, in this study also, 
we used SPT for testing of allergic to the patient. 
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SPT may provide information regarding type of allergen sensitivity although results of SPT 
must always be interpreted in combination with history and clinical findings.  The potential 
value of SPT also depends upon the quality of the allergen extracts used and the technical 
performance of the operator. Extracts should be biologically standardized with low batch-to-
batch variation. Solutions should be made up with preservative and generally stored in a 
refrigerator at +4 degree Celsius. There is variability of shelf life of allergens extract between 
different manufacturers. In general, SPT are more sensitive than in vitro determinations of 
allergen-specific IgE. SPT also can be performed to identify allergen before starting allergen-
specific immunotherapy. In addition, upon completion of SPT procedure, it serves 
educational value and provide a visual evidence to reinforce verbal advice to the patient about 
allergen avoidance measures. 
Table 2.5 - Indication of Skin Prick Test (European Standard) 
Indication 
rhinoconjunctivitis 
Asthma 
Urticarial 
anapylaxis 
atopic eczema 
food allergy 
drug allergy 
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Table 2. 6 - Relative Contraindication of SPT (European Standard) 
 
Relative contraindication  
Pregnancy (in view of a remote possibility of inducing a systemic allergic reaction that could 
induce uterine contractions or necessitate the use of epinephrine) 
severe eczema, dermographism 
Individual who is on antihistamines or other medications such as certain anti- 
depressants or calcineurin inhibitors 
 
The recommended method of skin prick testing includes the appropriate use of specific 
allergen extracts, positive and negative controls, interpretation of the tests after 15 – 20 
minutes of application. A positive result defined as a wheal ≥3 mm diameter (Heinzerling et 
al., 2013). 
Practices points for SPT: 
 Always check that patient is not on antihistamines before performing SPT 
 Always include positive (histamine) and negative (allergen diluent) control 
tests 
 A positive test is (arbitrarily) 3mm or more greater than the negative control 
 SPT should be performed on the flexor aspect of the forearm using a sterile 
lancet 
 The procedure should not be painful and not draw blood 
 Dermographism may confound results 
 A measurement of allergen-specific IgE concentration (RAST) is an 
alternative if skin prick test cannot be performed 
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SPT is considered as the conventional method to test for the presence of allergen-specific IgE 
and to detect IgE bound to the surface of mast cells in the skin. The principle of SPT is when 
a solution of allergen is applied to the skin at the volar surface of the forearm. The allergen 
will have contact with specific IgE bound to the surface of cutaneous mast cells upon skin 
pricked using lancet. The binding of the allergen leads to cell activation and the immediate 
release of mediators including histamine. Other mediators are also released but histamine 
appears to be the critical one as skin prick test becomes negative after taking oral 
antihistamines. The release of mediators result in a wheal and flare type reaction and the test 
is generally reported as the maximal wheal diameter after 15 to 20 minutes. The test is 
reported as positive if the diameter size of a wheal is 3mm or more than the control. 
These tests are simple, quick and the most sensitive method of detecting specific IgE. SPT 
are particularly helpful in excluding potential allergens as a cause of symptoms as false 
negatives are common. Although this test are extremely safe with only rare reports of 
generalized reaction, the risk of systemic absorption remains and anaphylaxis is a remote 
possibility in highly sensitized individuals. Testing should be performed by experienced 
personal and resuscitation equipment should always be available. 
  
2.6.3 Inflammatory markers 
Blood inflammatory marker is another option for patient when SPT is contraindicated. Such 
patients are those at high risk anaphylaxis, small children, severe dermatographism or severe 
eczematous dermatitis. There are few types of inflammatory markers that can be used as 
allergy markers in the human serum. 
 
